Allspring Global Investments Holdings, LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1890906
CHARLOTTE, NC
Position in GLUE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,539,139
+$2,087,005 QoQ
Shares Held
352,857
-10.0% QoQ
Ownership
0.414%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 193 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names. GLUE ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
170,829 | $158,490,019 | |
| 2 | EXEL |
Exelixis, Inc.
|
1,998,471 | $108,736,806 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
140,631 | $69,855,635 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
742,547 | $55,304,900 | |
| 5 | ASND |
Ascendis Pharma A/S
|
178,738 | $47,672,997 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
523,192 | $45,491,543 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,700 | $43,460,737 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
67,668 | $36,334,331 |
All Filings in GLUE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,539,139 | 352,857 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,452,134 | 392,227 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $422,654 | 26,955 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $182,263 | 24,597 | Shares | Defined | 2025-10-20 | |
| 2022-03-31 | $194,863 | 13,899 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $317,388 | 15,543 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||